Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors

Podobne zapisy

• Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
  od: Gopalakrishnan, Ramakrishnan, i wsp.
  Wydane: (2015)
• A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated Primary Effusion Lymphoma and blocks vFLIP K13-induced NF-κB
  od: Gopalakrishnan, Ramakrishnan, i wsp.
  Wydane: (2013)
• NEMO Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Encoded vFLIP K13-Induced Gene Expression and Protection against Death Receptor-Induced Cell Death, and Its N-Terminal 251 Residues Are Sufficient for This Process
  od: Tolani, Bhairavi, i wsp.
  Wydane: (2014)
• A Computational Profiling of Changes in Gene Expression and Transcription Factors Induced by vFLIP K13 in Primary Effusion Lymphoma
  od: Punj, Vasu, i wsp.
  Wydane: (2012)
• Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma
  od: Gopalakrishnan, Ramakrishnan, i wsp.
  Wydane: (2020)